IDEXX Laboratories Inc. Stock Underperforms Monday When Compared To Competitors
I'm PortAI, I can summarize articles.
IDEXX Laboratories Inc. shares fell 1.04% to $706.65 on Monday, marking the fourth consecutive day of losses. The stock underperformed compared to competitors like Johnson & Johnson, Medtronic PLC, and Boston Scientific Corp. The S&P 500 and Dow Jones also declined, contributing to a rough trading session. IDEXX is 8.22% below its 52-week high of $769.98.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments